Daniel Cole

Henry Ford Health System

Papers

1

Total Citations

3

H-Index

1

About

Daniel Cole is a urologic oncologist whose research centers on the intersection of advanced imaging and prostate cancer management, with a particular focus on refining diagnostic and prognostic accuracy. His most cited work, a 2020 study published in *Urology*, investigates the pathologic outcomes of patients with clinically significant prostate cancer who exhibit no suspicious PI-RADS lesions on preoperative MRI. This paper, garnering three citations, challenges the reliability of MRI in detecting all aggressive tumors, highlighting critical limitations in current imaging protocols and underscoring the need for more nuanced risk stratification. Cole’s contributions address a pressing clinical gap: how to identify high-risk disease when standard imaging appears negative. By correlating post-prostatectomy pathology with preoperative MRI findings, his work informs surgical planning and patient counseling, potentially reducing underdiagnosis. While his citation count is modest, this study represents a foundational step in a career dedicated to improving outcomes through evidence-based imaging-pathology correlations. For students and researchers, Cole’s research serves as a reminder that even small-scale studies can illuminate pivotal blind spots in clinical practice, driving future innovations in prostate cancer detection and treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging
3 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Henry Ford Health System

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago